The speed of progression towards obsessive-compulsive disorder

Imagem de Miniatura
Arquivos
art_THOMPSON_The_speed_of_progression_towards_obsessivecompulsive_disorder_2020.PDF.pdf (288.69 KB)
Citações na Scopus
20
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Autores
THOMPSON, Emma M.
TORRES, Albina R.
ALBERTELLA, Lucy
FERRAO, Ygor A.
TIEGO, Jeggan
SHAVITT, Roseli G.
ROSARIO, Maria Conceicao do
FONTENELLE, Leonardo F.
Autor de Grupo de pesquisa
Citação
JOURNAL OF AFFECTIVE DISORDERS, v.264, p.181-186, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: There is current interest in the elaboration of early intervention programs for obsessive-compulsive disorder (OCD). To this end, it is important to investigate the speed of progression from subthreshold symptoms to diagnosable OCD. In this study, we have retrospectively investigated the speed of progression towards full-blown OCD and sociodemographic and clinical factors associated with a faster transition. Methods: Patients enrolled in the Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders (N = 954) were interviewed with a comprehensive assessment battery that included the interval (in years) between the onset of subthreshold OCD symptoms and the onset of full-blown OCD. Results: It took a median of 7 years (interquartile range: 2-13 years) for subthreshold symptoms to convert to diagnosable OCD. Faster OCD onset was associated with lower age at the time of assessment, male gender, being in new romantic states as precipitants for compulsions, greater severity of sexual/religious symptoms and lower severity of hoarding and YBOCS compulsions severity scores, greater rates of generalized anxiety disorder and agoraphobia without panic disorder, and negative family history for OCD. Limitations: The retrospective design of this study allowed for susceptibility to memory bias about age at onset of OCD symptoms. We were unable to capture progressions taking less than 12 months. Conclusions: We could identify a specific phenotype that was more likely to escalate rapidly to clinical levels within this large clinical sample. This phenomenon may be particularly relevant in the context of selecting individuals for early intervention initiatives in situations when resources are scarce.
Palavras-chave
OCD, Etiology, Course, Onset, Subthreshold symptoms, Subclinical symptoms
URI
https://observatorio.fm.usp.br/handle/OPI/35510
Referências
  1. Abramowitz J, 2001, PSYCHOSOMATICS, V42, P429, DOI 10.1176/appi.psy.42.5.429
  2. Albert U, 2019, CURR NEUROPHARMACOL, V17, P681, DOI 10.2174/1570159X16666180620155941
  3. Alonso P, 2001, J CLIN PSYCHIAT, V62, P535, DOI 10.4088/JCP.v62n07a06
  4. Altamura AC, 2013, MOD TR PHARMACOPSYCH, V29, P111, DOI 10.1159/000351950
  5. Anuja P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189832
  6. Ayers CR, 2015, AM J GERIAT PSYCHIAT, V23, P416, DOI 10.1016/j.jagp.2014.05.009
  7. BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893
  8. BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004
  9. Capello E, 2004, NEUROL SCI, V25, pS361, DOI 10.1007/s10072-004-0341-1
  10. Chang KK, 2015, J CHILD ADOL PSYCHOP, V25, P3, DOI 10.1089/cap.2014.0084
  11. Coles M.E., 2012, COGNIT THER RES, V36
  12. Coles ME, 2011, BEHAV COGN PSYCHOTH, V39, P579, DOI 10.1017/S135246581100004X
  13. de Mathis MA, 2008, EUR PSYCHIAT, V23, P187, DOI 10.1016/j.eurpsy.2008.01.002
  14. DEGONDA M, 1993, EUR ARCH PSY CLIN N, V243, P16, DOI 10.1007/BF02191519
  15. Dell'Osso B, 2010, WORLD J BIOL PSYCHIA, V11, P59, DOI 10.3109/15622970903418544
  16. Delorme R, 2005, PSYCHOL MED, V35, P237, DOI 10.1017/S0033291704003253
  17. DEMATHIS MA, 2011, BRAZ J PSYCHIAT, V33, P390
  18. Eisen JL, 1998, AM J PSYCHIAT, V155, P102, DOI 10.1176/ajp.155.1.102
  19. Ferrao YA, 2006, J AFFECT DISORDERS, V94, P199, DOI 10.1016/j.jad.2006.04.019
  20. Feygin DL, 2006, PROG NEURO-PSYCHOPH, V30, P854, DOI 10.1016/j.pnpbp.2006.01.009
  21. Fineberg N.A., 2019, EUR NEUROPSYCHOPHARM
  22. Fineberg NA, 2013, INT J PSYCHIAT CLIN, V17, P188, DOI 10.3109/13651501.2013.777745
  23. First M. B., 1997, STRUCTURED CLIN INTE
  24. Fontenelle LF, 2005, REV BRAS PSIQUIATR, V27, P201, DOI 10.1590/S1516-44462005000300008
  25. Fostick L, 2012, WORLD J BIOL PSYCHIA, V13, P312, DOI 10.3109/15622975.2011.607848
  26. Fullana MA, 2010, J AFFECT DISORDERS, V124, P291, DOI 10.1016/j.jad.2009.11.020
  27. Fullana MA, 2009, AM J PSYCHIAT, V166, P329, DOI 10.1176/appi.ajp.2008.08071006
  28. Geller DA, 2001, J NERV MENT DIS, V189, P471, DOI 10.1097/00005053-200107000-00009
  29. Ghaziuddin N, 2017, J CHILD ADOL PSYCHOP, V27, P359, DOI 10.1089/cap.2016.0180
  30. GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006
  31. HAVLICEK LL, 1976, PERCEPT MOTOR SKILL, V43, P1319, DOI 10.2466/pms.1976.43.3f.1319
  32. Hernandez-Avila CA, 2004, DRUG ALCOHOL DEPEN, V74, P265, DOI 10.1016/j.drugalcdep.2004.02.001
  33. Jaspers-Fayer F, 2017, J CHILD ADOL PSYCHOP, V27, P332, DOI 10.1089/cap.2016.0031
  34. Juckel G, 2014, J NERV MENT DIS, V202, P889, DOI 10.1097/NMD.0000000000000220
  35. Katz BS, 2015, J CLIN NEUROSCI, V22, P398, DOI 10.1016/j.jocn.2014.07.001
  36. Kichuk SA, 2013, PROG NEURO-PSYCHOPH, V44, P233, DOI 10.1016/j.pnpbp.2013.02.003
  37. Kim JE, 2014, PSYCHIAT RES, V215, P134, DOI 10.1016/j.psychres.2013.07.036
  38. Kishore VR, 2004, EUR PSYCHIAT, V19, P202, DOI 10.1016/j.eurpsy.2003.12.005
  39. Leckman J., 2002, UNPUB
  40. Leckman JF, 1999, CHILD ADOL PSYCH CL, V8, P635
  41. Lensi P, 1996, BRIT J PSYCHIAT, V169, P101, DOI 10.1192/bjp.169.1.101
  42. Maina G, 2000, CNS Spectr, V5, P31
  43. Mancebo MC, 2008, COMPR PSYCHIAT, V49, P43, DOI 10.1016/j.comppsych.2007.05.016
  44. Mataix-Cols D, 2002, PSYCHOTHER PSYCHOSOM, V71, P255, DOI 10.1159/000064812
  45. Mataix-Cols D, 2010, DEPRESS ANXIETY, V27, P556, DOI 10.1002/da.20693
  46. Miguel EC, 2008, REV BRAS PSIQUIATR, V30, P185, DOI 10.1590/S1516-44462008000300003
  47. Millet B, 2004, J AFFECT DISORDERS, V79, P241, DOI 10.1016/S0165-0327(02)00351-8
  48. Morris DR, 2005, PSYCHOSOMATICS, V46, P458, DOI 10.1176/appi.psy.46.5.458
  49. Murphy TK, 2014, PSYCHIAT CLIN N AM, V37, P353, DOI 10.1016/j.psc.2014.06.001
  50. Orlovska S, 2017, JAMA PSYCHIAT, V74, P740, DOI 10.1001/jamapsychiatry.2017.0995
  51. Pinto A, 2006, J CLIN PSYCHIAT, V67, P703, DOI 10.4088/JCP.v67n0503
  52. Post RM, 1998, BIOL PSYCHIAT, V44, P193, DOI 10.1016/S0006-3223(98)00144-9
  53. Rajarethinam RP, 2000, DEPRESS ANXIETY, V12, P238, DOI 10.1002/1520-6394(2000)12:4<238::AID-DA8>3.0.CO;2-R
  54. Roh D, 2011, J NERV MENT DIS, V199, P690, DOI 10.1097/NMD.0b013e318229d209
  55. Rosario-Campos MC, 2006, MOL PSYCHIATR, V11, P495, DOI 10.1038/sj.mp.4001798
  56. Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94
  57. Shrestha R, 2015, PSYCHIAT CLIN N AM, V38, P221, DOI 10.1016/j.psc.2015.01.001
  58. Tavares H, 2003, J CLIN PSYCHIAT, V64, P433, DOI 10.4088/JCP.v64n0413
  59. Taylor S, 2011, CLIN PSYCHOL REV, V31, P1083, DOI 10.1016/j.cpr.2011.06.007
  60. Tennov D., 1998, LOVE LIMERENCE EXPER
  61. Tolin DF, 2010, DEPRESS ANXIETY, V27, P829, DOI 10.1002/da.20684
  62. Torres AR, 2011, J CLIN PSYCHIAT, V72, P17, DOI 10.4088/JCP.09m05651blu
  63. Tukel R, 2005, DEPRESS ANXIETY, V21, P112, DOI 10.1002/da.20065
  64. Velloso P, 2016, EUR PSYCHIAT, V38, P1, DOI 10.1016/j.eurpsy.2016.05.003
  65. Wang XM, 2012, J AFFECT DISORDERS, V136, P498, DOI 10.1016/j.jad.2011.11.001

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - LIM/23